Episode 326 - Jonathan Rigby - CEO and Chairman of Sernova

In this episode of the Diabetes Innovators Series, Rob interviews
Jonathan Rigby, CEO of Sernova Biotherapeutics, about the
innovative approaches to treating type 1 diabetes, particularly
through the development of a biohybrid organ known as the cell
pouch. Jonathan shares his personal journey as a type 1 diabetic
and discusses the clinical trials, patient selection, and the
future of diabetes treatment, including the challenges of
immunosuppression and the complexities of daily diabetes
management. The conversation emphasizes the importance of
innovation in diabetes care and the hope for a future where
patients can achieve insulin independence. Chapters 00:00
Introduction to Diabetes and Innovation 02:51 The Cell Pouch
Biohybrid Organ 05:53 Clinical Trials and Patient Selection 08:48
Living with Type 1 Diabetes 11:51 Future of Diabetes Treatment
14:47 Immunosuppressants and Cell Acceptance 17:48 The Complexity
of Diabetes Management 20:44 Conclusion and Future Outlook
Resources: Sernova Jonathan Rigby LinkedIn